Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress contributes to hair graying and loss as we age.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Fetal skin heals without scarring due to unique cells and processes not present in adult skin healing.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

Bariatric surgery affects skin health, causing both direct complications and changes in existing skin conditions, often related to nutritional deficiencies.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Tissue expansion is an effective treatment for certain types of hair loss, providing immediate coverage with hair-bearing skin.

Frontal Fibrosing Alopecia might be an autoimmune disease.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Blocking interferon-gamma might help treat various autoimmune diseases.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.